Calcineurin Autoinhibitory Peptide

The peptide is a specific inhibitor for calcineurin phosphatase, and corresponds to the residues 467-491 within the inhibitory domain of human calcineurin alpha subunit. It inhibits Mn2+-stimulated calcineurin activity (IC50 = 10 uM using 32P-myosin light chain as substrate), but does not affect Ni2+-stimulated enzyme activity.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: R0845

CAS No:148067-21-4

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C124H205N39O39S2
M.W/Mr.
2930.34
Sequence
ITSFEEAKGLDRINERMPPRRDAMP
Labeling Target
Calcineurin
Appearance
White to off white powder
Purity
>98 %

Calcineurin Autoinhibitory Peptide is a synthetic peptide derivative designed to mimic the endogenous autoinhibitory domain of calcineurin, a calcium/calmodulin-dependent serine/threonine phosphatase. As a potent and selective inhibitor, this peptide plays a critical role in dissecting calcineurin function in cellular signaling pathways. Its sequence enables competitive binding to the catalytic site, thereby modulating downstream dephosphorylation events. Researchers leverage its specificity to interrogate the regulatory mechanisms of calcineurin in diverse biological contexts, making it a valuable tool in signal transduction and phosphatase research.

Enzyme inhibition studies: The peptide serves as a robust molecular tool for probing calcineurin activity in vitro and in cell-based assays. By effectively blocking the phosphatase's active site, it allows investigators to delineate the precise contribution of calcineurin to cellular processes such as T-cell activation, neuronal signaling, and muscle differentiation. Its use facilitates the characterization of calcineurin-dependent dephosphorylation events, enabling the identification of direct substrates and regulatory proteins involved in calcium-mediated signaling cascades.

Signal transduction research: Employing the autoinhibitory peptide in cellular models provides a controlled means to investigate the downstream effects of calcineurin inhibition. By selectively interfering with this pathway, researchers can assess alterations in transcription factor activation, gene expression profiles, and cytoskeletal dynamics. Such studies are instrumental in uncovering the broader impact of calcium signaling on cellular adaptation, growth, and differentiation, as well as in mapping cross-talk with other phosphatase-regulated pathways.

Peptide-protein interaction analysis: The sequence-specific binding properties of the peptide make it an excellent probe for studying protein-protein interactions involving calcineurin. Its application in pull-down assays, co-immunoprecipitation, or surface plasmon resonance experiments enables the dissection of binding kinetics and affinities between calcineurin and its natural partners. These insights are crucial for understanding the molecular determinants of substrate recognition and regulatory complex formation in phosphatase signaling networks.

Peptide inhibitor screening: The autoinhibitory peptide is frequently used as a benchmark or positive control in the development and evaluation of novel calcineurin inhibitors. By comparing the inhibitory potency of new compounds against the established activity profile of the peptide, researchers can rapidly assess specificity, efficacy, and potential off-target effects. This approach accelerates the optimization of small molecules or biologics targeting phosphatase-mediated signaling, supporting drug discovery and chemical biology initiatives.

Cellular pathway mapping: In systems biology and functional genomics, the peptide enables precise modulation of calcineurin activity within complex cellular environments. Its incorporation into experimental workflows allows for the temporal and spatial control of phosphatase inhibition, facilitating the mapping of signaling networks and the identification of compensatory mechanisms. Such applications are essential for elucidating the integrative roles of calcineurin in physiological and stress-responsive pathways, advancing our understanding of cellular regulation at the systems level.

Source#
Synthetic
Long-term Storage Conditions
Soluble in water
Solubility
-20 °C
InChI
InChI=1S/C124H205N39O39S2/c1-12-62(5)94(127)114(195)160-96(66(9)165)116(197)158-83(60-164)112(193)154-79(55-67-26-15-14-16-27-67)109(190)149-75(38-41-91(172)173)105(186)148-73(36-39-89(168)169)100(181)141-64(7)97(178)144-68(28-17-18-44-125)99(180)140-59-88(167)143-78(54-61(3)4)108(189)156-82(58-93(176)177)111(192)147-72(32-22-48-139-124(134)135)106(187)159-95(63(6)13-2)115(196)157-80(56-87(126)166)110(191)150-74(37-40-90(170)171)104(185)146-69(29-19-45-136-121(128)129)102(183)153-77(43-53-204-11)117(198)162-50-24-34-85(162)119(200)161-49-23-33-84(161)113(194)151-71(31-21-47-138-123(132)133)101(182)145-70(30-20-46-137-122(130)131)103(184)155-81(57-92(174)175)107(188)142-65(8)98(179)152-76(42-52-203-10)118(199)163-51-25-35-86(163)120(201)202/h14-16,26-27,61-66,68-86,94-96,164-165H,12-13,17-25,28-60,125,127H2,1-11H3,(H2,126,166)(H,140,180)(H,141,181)(H,142,188)(H,143,167)(H,144,178)(H,145,182)(H,146,185)(H,147,192)(H,148,186)(H,149,190)(H,150,191)(H,151,194)(H,152,179)(H,153,183)(H,154,193)(H,155,184)(H,156,189)(H,157,196)(H,158,197)(H,159,187)(H,160,195)(H,168,169)(H,170,171)(H,172,173)(H,174,175)(H,176,177)(H,201,202)(H4,128,129,136)(H4,130,131,137)(H4,132,133,138)(H4,134,135,139)/t62-,63-,64-,65-,66+,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,85-,86-,94-,95-,96-/m0/s1
InChI Key
JRQDGUSHUYLSHC-TVQDNDAUSA-N
Isomeric SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N2CCC[C@H]2C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N4CCC[C@H]4C(=O)O)N
BoilingPoint
N/A
Melting Point
N/A

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicecGMP Peptide ServiceEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide CDMOPeptide Synthesis ServicesPeptide Modification ServicesPeptide Analysis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers